M.E. Allison & Co’s Bristol-Myers Squibb BMY Stock Holding History

M.E. Allison & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$519K	Buy	8,319 +1	+0%	+$63	0.29%	91
2026 Q2	$479K	Sell	8,318 -498	-6%	-$28.6K	0.28%	97
2026 Q1	$535K	Buy	8,816 +2	+0%	+$117	0.35%	76
2025 Q4	$475K	Buy	8,814 +1	+0%	+$48	0.32%	85
2025 Q3	$397K	Buy	8,813 +52	+0.6%	+$2.43K	0.28%	94
2025 Q2	$406K	Buy	8,761 +1,348	+18%	+$66.2K	0.33%	81
2025 Q1	$452K	Buy	7,413 +3	+0%	+$175	0.45%	66
2024 Q4	$419K	Buy	+7,410	New	+$414K	0.46%	65

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

M.E. Allison & Co's BMY Position: Q3 2026 in Review

M.E. Allison & Co increased its Bristol-Myers Squibb (BMY) stake by 0.01% in Q3 2026, buying an estimated $63 and bringing the position to 8,319 shares worth $519K. The position accounts for 0.29% of the portfolio, ranked #91.

M.E. Allison & Co first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $535K in Q1 2026. 623 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

M.E. Allison & Co held 8,319 shares of Bristol-Myers Squibb worth $519K as of Q3 2026.
M.E. Allison & Co bought 1 Bristol-Myers Squibb share in Q3 2026, an estimated $63.
Bristol-Myers Squibb made up 0.29% of M.E. Allison & Co's portfolio in Q3 2026, its #91 holding.
M.E. Allison & Co first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
M.E. Allison & Co's Bristol-Myers Squibb position peaked at $535K in Q1 2026.
623 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.